Anthropic announces AI workbench for scientists, plans drug development
AI company Anthropic has launched Claude Science, a new AI workbench for researchers, and revealed plans to develop its own drugs.
AI firm Anthropic has unveiled Claude Science, a new AI workbench designed for scientists that integrates fragmented tools and datasets into a single environment, capable of generating scientific figures and visualizations.
The company, already recognized for its coding tools and AI models, announced the launch at the "The Briefing: AI for Science" event. Anthropic sees AI as a key enabler for accelerating scientific discovery and the development of healthcare interventions.
Anthropic has already secured a client base within the biotech and pharmaceutical sectors utilizing Claude. The company is leveraging its established expertise in AI to further its reach into scientific research applications.
Beyond the introduction of Claude Science, Anthropic has also stated its intention to develop drugs. This move signifies an expansion of the company's operations from providing AI solutions to directly participating in the pharmaceutical development pipeline.